1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
30.36%
Positive revenue growth while MAXN is negative. John Neff might see a notable competitive edge here.
101.11%
Gross profit growth 1.25-1.5x MAXN's 73.39%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
665.55%
EBIT growth above 1.5x MAXN's 71.83%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
665.55%
Operating income growth above 1.5x MAXN's 66.50%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
2011.37%
Net income growth above 1.5x MAXN's 73.10%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
1804.76%
EPS growth of 1804.76% while MAXN is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
2005.26%
Diluted EPS growth above 1.5x MAXN's 73.09%. David Dodd would see if there's a robust moat protecting these shareholder gains.
4.77%
Share change of 4.77% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
3.70%
Diluted share change of 3.70% while MAXN is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
169.34%
OCF growth above 1.5x MAXN's 93.92%. David Dodd would confirm a clear edge in underlying cash generation.
68.26%
FCF growth 50-75% of MAXN's 91.23%. Martin Whitman would see if structural disadvantages exist in generating free cash.
-8.27%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-8.27%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-8.27%
Negative 3Y CAGR while MAXN stands at 7.06%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-93.35%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-93.35%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-93.35%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
123.37%
Positive 10Y CAGR while MAXN is negative. John Neff might see a substantial advantage in bottom-line trajectory.
123.37%
Positive 5Y CAGR while MAXN is negative. John Neff might view this as a strong mid-term relative advantage.
123.37%
Positive short-term CAGR while MAXN is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.43%
Our AR growth while MAXN is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
24.59%
We show growth while MAXN is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
63.80%
Positive asset growth while MAXN is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
70.33%
Positive BV/share change while MAXN is negative. John Neff sees a clear edge over a competitor losing equity.
No Data
No Data available this quarter, please select a different quarter.
29.66%
R&D growth drastically higher vs. MAXN's 3.39%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
13.79%
We expand SG&A while MAXN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.